Showing 1 - 9 results of 9 for search 'Annemiek M E Walenkamp', query time: 0.04s
Refine Results
-
1
Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy by Emile B. Veenstra, Adrienne H. Brouwers, Derk Jan A. de Groot, Johannes Hofland, Annemiek M. E. Walenkamp, Tessa Brabander, Wouter T. Zandee, Walter Noordzij
Published 2022-06-01
Article -
2
-
3
Implementation and evaluation of a physical activity counselling programme in primary care among cancer survivors: SoDA study protocol by Geertruida H De Bock, Marjolein Y Berger, Daan Brandenbarg, Famke Huizinga, Nico-Derk Lodewijk Westerink, Annette J Berendsen, Annemiek M E Walenkamp, Mathieu H G de Greef
Published 2022-03-01
Article -
4
-
5
Subclassification of newly diagnosed glioblastomas through an immunohistochemical approach. by Siobhan Conroy, Frank A E Kruyt, Justin V Joseph, Veerakumar Balasubramaniyan, Krishna P Bhat, Michiel Wagemakers, Roelien H Enting, Annemiek M E Walenkamp, Wilfred F A den Dunnen
Published 2014-01-01
Article -
6
The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors by Gilles N. Stormezand, Romano S. B. H. Schreuder, Adrienne H. Brouwers, Riemer H. J. A. Slart, Philip H. Elsinga, Annemiek M. E. Walenkamp, R. A. J. O. Dierckx, Andor W. J. M. Glaudemans, Gert Luurtsema
Published 2021-09-01
Article -
7
Insulinoma Manifesting Early Postpartum: Case Report and Review of the Literature by Eske Christiane Gertje, MD, Annemiek M.E. Walenkamp, MD, PhD, Andor W.J.M. Glaudemans, MD, Sander A.J.C. Ijtsma, MD, Klaas Hoogenberg, MD, PhD, Robin P.F. Dullaart, MD, PhD
Published 2015-01-01
Article -
8
CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy by Urszula M. Domanska, Hetty Timmer-Bosscha, Wouter B. Nagengast, Thijs H. Oude Munnink, Roeliene C. Kruizinga, Hildo J.K. Ananias, Nathalie M. Kliphuis, Gerwin Huls, Elisabeth G.E. De Vries, Igle J. de Jong, Annemiek M.E. Walenkamp
Published 2012-08-01
Article -
9
Effects of supervised exercise during adjuvant endocrine therapy in overweight or obese patients with breast cancer: The I-MOVE study by Harm L. Ormel, Carolina P. Schröder, Gabriela G.F. van der Schoot, Nico-Derk L. Westerink, Annette W.G. van der Velden, Boelo Poppema, Aline H. Vrieling, Jourik A. Gietema, Annemiek M.E. Walenkamp, Anna K.L. Reyners
Published 2021-08-01
Article